BioReference Laboratories, Inc. Announces Acquisition Of Maryland Pathology/Cytology Laboratory And Completion of GeneDx Acquisition

ELMWOOD PARK, N.J.--(BUSINESS WIRE)--BioReference Laboratories, Inc. (NASDAQ: BRLI) announced that it has acquired the laboratory operations of Diagnostic Pathology Services, Inc. “DPS” of Clarksburg, Maryland offers specialized testing in the areas of hematopathology, cytology and anatomic pathology and expects revenues for the current calendar year to be in excess of $3.5 million. The acquisition will bring to BRLI some key additions to its technical and professional staff and extend service and support to its customers in the Middle Atlantic States currently served by DPS in Maryland, Virginia, and Washington DC.

Back to news